Organon & Co. (OGN)

Organon & Co. Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	6,263	6,174	6,304	6,532	7,777
Revenue Growth (YoY)	1.44%	-2.06%	-3.49%	-16.01%	-20.46%
Cost of Revenue	2,515	2,294	2,382	2,119	2,274
Gross Profit	3,748	3,880	3,922	4,413	5,503
Selling, General & Admin	1,893	1,704	1,668	1,356	1,443
Research & Development	528	471	339	210	220
Other Operating Expenses	85	150	124	51	144
Operating Expenses	2,506	2,325	2,131	1,617	1,807
Operating Income	1,242	1,555	1,791	2,796	3,696
Interest Expense / Income	527	422	258	0	0
Other Expense / Income	42	11	4	140	88
Pretax Income	673	1,122	1,529	2,656	3,608
Income Tax	-350	205	178	496	390
Net Income	1,023	917	1,351	2,160	3,218
Net Income Growth	11.56%	-32.12%	-37.45%	-32.88%	49.47%
Shares Outstanding (Basic)	255	254	254	254	254
Shares Outstanding (Diluted)	256	255	254	254	254
Shares Change	0.43%	0.38%	0.27%	-	-
EPS (Basic)	4.01	3.61	5.33	8.52	12.69
EPS (Diluted)	3.99	3.59	5.31	8.52	12.69
EPS Growth	11.14%	-32.39%	-37.68%	-32.86%	-
Free Cash Flow	549	669	2,273	1,937	2,679
Free Cash Flow Per Share	2.15	2.63	8.96	7.64	10.57
Dividend Per Share	0.840	1.120	0.560	-	-
Dividend Growth	-25.00%	100.00%	-	-	-
Gross Margin	59.84%	62.84%	62.21%	67.56%	70.76%
Operating Margin	19.83%	25.19%	28.41%	42.80%	47.52%
Profit Margin	16.33%	14.85%	21.43%	33.07%	41.38%
Free Cash Flow Margin	8.77%	10.84%	36.06%	29.65%	34.45%
Effective Tax Rate	-52.01%	18.27%	11.64%	18.67%	10.81%
EBITDA	1,436	1,756	1,982	2,798	3,941
EBITDA Margin	22.93%	28.44%	31.44%	42.84%	50.68%
Depreciation & Amortization	236	212	195	142	333
EBIT	1,200	1,544	1,787	2,656	3,608
EBIT Margin	19.16%	25.01%	28.35%	40.66%	46.39%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).